Literature DB >> 15300667

Improvement of blepharospasm with Zolpidem.

Nélida Susana Garretto1, José A Bueri, Roberto D Rey, Tomoko Arakaki, Gabriela V Nano, Marcela Mancuso.   

Abstract

Zolpidem (ZLP) is an imidazopyridine that binds to GABA receptors. We report on improvement of blepharospasm in 3 patients treated with ZLP. The GABAergic action of this drug on the output structures of the basal ganglia could explain the improvement of blepharospasm in these patients. Copyright 2004 Movement Disorder Society

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15300667     DOI： 10.1002/mds.20085

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  8 in total

Review 1.  Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.

Authors:  Romy Hoque; Andrew L Chesson
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

2.  Efficacy of zolpidem for dystonia: a study among different subtypes.

Authors:  Yoshimichi Miyazaki; Wataru Sako; Kotaro Asanuma; Yuishin Izumi; Tetsuro Miki; Ryuji Kaji
Journal:  Front Neurol       Date:  2012-04-17       Impact factor: 4.003

3.  Zolpidem : Forensic aspects for the toxicologist and pathologist.

Authors:  Timothy P Rohrig; Christine M Moore
Journal:  Forensic Sci Med Pathol       Date:  2005-06       Impact factor: 2.456

4.  A case with improvement of blepharospasm by zolpidem.

Authors:  Munkyung Sunwoo; Junghee Cho; Jun Hong Lee; Gyu Sik Kim; Jong Hun Kim; Sun-Ah Choi
Journal:  J Mov Disord       Date:  2011-04-30

5.  High-dose zolpidem dependence - Psychostimulant effects? A case report and literature review.

Authors:  Abhijna Chandan Chattopadhyay; Lekhansh Shukla; Arun Kandasamy; Vivek Benegal
Journal:  Ind Psychiatry J       Date:  2016 Jul-Dec

6.  Dystonic Dysarthria in Wilson Disease: Efficacy of Zolpidem.

Authors:  Aurélia Poujois; Michaela Pernon; Jean-Marc Trocello; France Woimant
Journal:  Front Neurol       Date:  2017-10-31       Impact factor: 4.003

7.  Efficacy and Safety of Zolpidem for Focal Dystonia After Neurosurgical Treatments: A Retrospective Cohort Study.

Authors:  Shiro Horisawa; Kotaro Kohara; Hiroki Ebise; Masahiko Nishitani; Takakazu Kawamata; Takaomi Taira
Journal:  Front Neurol       Date:  2022-05-03       Impact factor: 4.003

Review 8.  Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease.

Authors:  Antonio Daniele; Francesco Panza; Antonio Greco; Giancarlo Logroscino; Davide Seripa
Journal:  Parkinsons Dis       Date:  2016-05-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.